BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 35658326)

  • 1. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
    Bao L; Ding Y; Cai Q; Ning Y; Hu W; Xue X; Sun H; Hua K; Zhou X; Yi X
    Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report.
    Song L; Li Q; Yang K; Yin R; Wang D
    Medicine (Baltimore); 2018 Jun; 97(24):e11107. PubMed ID: 29901630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience.
    Hou Y; Bruehl FK; McHugh KE; Reynolds JP
    J Am Soc Cytopathol; 2020; 9(2):89-94. PubMed ID: 31734259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
    Yoshino K; Kurita T; Takahashi F; Nagase S;
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1570-1579. PubMed ID: 35633031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery].
    Huang XT; Ji M; Zhao Z; He NN; Li Y; Xu PL; Zhang JF
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):341-348. PubMed ID: 34034421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of prognosis and associated factors in multiple recurrent epithelial ovarian cancer with three times or more cytoreductive surgeries].
    Zou RY; Yuan L; Chen M; Yao LQ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Mar; 58(3):198-206. PubMed ID: 36935197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and prognostic features of ovarian endometrioid carcinoma with synchronous endometrial lesions].
    Yao LQ; Zhou L; Dai L; Ye X; Zhu HL; Cheng HY; Ma RQ; Cui H; Chang XH
    Zhonghua Fu Chan Ke Za Zhi; 2021 Mar; 56(3):200-207. PubMed ID: 33874715
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
    Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
    Mulligan AM; Plotkin A; Rouzbahman M; Soslow RA; Gilks CB; Clarke BA
    Am J Surg Pathol; 2010 Aug; 34(8):1132-8. PubMed ID: 20588176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.